United States · FDA National Drug Code directory
PARSABIV
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55513-742_52286976-a97a-4b77-b678-f40ab5aa7133
- Product NDC
- 55513-742
- Form
- INJECTION, SOLUTION
- Composition / generic term
- etelcalcetide
- Labeler
- Amgen, Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170403
- Source listing expiry
- 20271231
Source-listed ingredients
- ETELCALCETIDE HYDROCHLORIDE — 10 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 CARTON (55513-742-10) / 2 mL in 1 VIAL, SINGLE-DOSE (55513-742-01) · 55513-742-10
- 10 VIAL, SINGLE-DOSE in 1 CARTON (55513-742-20) / 2 mL in 1 VIAL, SINGLE-DOSE (55513-742-01) · 55513-742-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →